ARTICLE | Finance
Financial Engineering Payoff
Cardio play Ikaria files for $200M IPO; neurology play NuPathe gets in the queue
May 17, 2010 7:00 AM UTC
Profitable cardiovascular and pulmonary company Ikaria Inc. filed for an IPO on Friday last week to raise up to $200 million.
Ikaria markets INOmax nitric oxide for inhalation to treat term and near-term infants with hypoxic respiratory failure. The company had $274.6 million in revenue in 2009...